Portfolio of Diabetes Stocks

Here is a sample of 12 stocks that provide diabetes treatments and monitoring.

12 Diabetes Stocks

& Monthly Returns

& Snapshot

Recent Prices
& Trendline

Abbott LaboratoriesABT
Eli LillyLLY
Insulet CorporationPODD
Lexicon PharmaceuticalsLXRX
MannKind Corp.MNKD
Novo NordiskNVO
Provention BioPRVB
Senseonics HoldingsSENS
Tandem Diabetes CareTNDM
Sparkline weekly price charts based on Alpha Vantage data.

Portfolio Values

To inspect the performance of the Diabetes Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 11 stocks included in the portfolio computations are: ABT, AZN, DXCM, LLY, PODD, LXRX, MNKD, MDT, NVO, SENS and TNDM. The current value of the portfolio assumes that $909.09 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. PRVB was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $37,612. The percent return is 276.12%. The annualized return is 30.34%.

Portfolio Value Chart for Last 100 Daily Closes

Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks